Optimal Sites for Tirzepatide Users: A Quick Guide If you are in early dose titration (2.5 mg or 5 mg) Try the Abdomen
Ro Body: Best for Brand-Name Access and Insurance Navigation Ro Body is the only program in our 2026 ranking with no FDA warning letters, no DOJ referrals, and no patent lawsuits against it
Holst JJ, Albrechtsen NJ, Gabe MB, Rosenkilde MM
Ask your provider to support your appeal with chart notes, lab results, and a written letter of medical necessity
The fact that 600,000 people chose "I might throw up" over "I have to give myself a shot" is the most relatable healthcare data point I've seen in a while
Pasireotide long-acting release (PAS-LAR) has also been reported to lower serum GLP-1 and GIP levels in phase 1 studies conducted on healthy volunteers 21